300435.SHE Hangzhou Zhongtai Cryogenic Technology Corp
- Market cap
- CNY 4.90B
- P/E
- 19.8x
- P/B
- 1.36x
- ROE
- 4.9%
- Dividend yield
- 1.62%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300435.SHE undervalued?
Graham number300435.SHE trades 9.7% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Hangzhou Zhongtai Cryogenic Technology Corp fundamental analysis
No fundamental analysis for Hangzhou Zhongtai Cryogenic Technology Corp yet.
Hangzhou Zhongtai Cryogenic Technology Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Hangzhou Zhongtai Cryogenic Technology Corp
Hangzhou Zhongtai Cryogenic Technology Corporation engages in the research and development, manufacturing, and service of cryogenic key equipment and plant packages in China. The company offers engineering package services, such as natural gas engineering, air separation, Syngas cryogenic separation, olefins separation, specialty gas, and chemical gas purification; EPC services; nitrogen production services; and hydrogen energy solutions, including hydrogen production, hydro…
Full company profileHangzhou Zhongtai Cryogenic Technology Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Hangzhou Zhongtai Cryogenic Technology Corp annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 337M | 486M | 595M | 1.03B | 1.98B | 2.41B | 3.26B | 3.05B | 2.72B | 2.75B | 2.08B |
| Gross Profit | 108M | 128M | 151M | 230M | 411M | 456M | 554M | 589M | 510M | 817M | 436M |
| Operating Income | 65.5M | 49.1M | 68.6M | 91.4M | 269M | 306M | 345M | 432M | -27.0M | 558M | 218M |
| EBITDA | 68.1M | 58.3M | 61.4M | 99.3M | 323M | 332M | 390M | 478M | 380M | 680M | 201M |
| Net Income | 56.9M | 60.2M | 67.6M | 77.4M | 196M | 245M | 278M | 350M | -78.0M | 450M | 170M |
| EPS | 0.23 | 0.25 | 0.27 | 0.29 | 0.52 | 0.65 | 0.73 | 0.91 | -0.20 | 1.17 | 0.44 |
| Balance Sheet | |||||||||||
| Total Assets | 1.02B | 1.31B | 1.42B | 2.88B | 3.45B | 3.92B | 4.68B | 5.42B | 4.54B | 4.65B | 4.92B |
| Total Liabilities | 320M | 545M | 604M | 771M | 1.15B | 1.39B | 1.86B | 2.23B | 1.50B | 1.16B | 1.40B |
| Shareholders' Equity | 699M | 765M | 814M | 2.11B | 2.29B | 2.52B | 2.82B | 3.17B | 2.98B | 3.42B | 3.46B |
| Cash & Short-term Investments | 288M | 241M | 260M | 367M | 748M | 947M | 1.28B | 1.77B | 1.01B | 414M | 241M |
| Total Debt | 55.0M | 128M | 150M | 155M | 257M | 315M | 663M | 781M | 124M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 50.1M | 25.0M | 103M | 131M | 419M | 315M | 288M | 398M | 325M | 489M | - |
| Capital Expenditure | 6.60M | 8.08M | 13.6M | 8.62M | 283M | 214M | 261M | 260M | 76.7M | 43.6M | 32.0M |
| Free Cash Flow | 43.5M | 16.9M | 89.1M | 122M | 137M | 101M | 27.5M | 138M | 248M | 445M | 247M |
| Ratios | |||||||||||
| ROE | 8.1% | 7.9% | 8.3% | 3.7% | 8.5% | 9.7% | 9.9% | 11.1% | -2.6% | 13.2% | 4.9% |
| ROA | 5.6% | 4.6% | 4.8% | 2.7% | 5.7% | 6.3% | 5.9% | 6.5% | -1.7% | 9.7% | 3.5% |
| Net Profit Margin | 16.9% | 12.4% | 11.4% | 7.5% | 9.9% | 10.2% | 8.5% | 11.5% | -2.9% | 16.4% | 8.2% |
| Debt to Equity | 0.08x | 0.17x | 0.18x | 0.07x | 0.11x | 0.12x | 0.24x | 0.25x | 0.04x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Hangzhou Zhongtai Cryogenic Technology Corp dividends
- Dividend yield
- 1.62%
- Forward dividend
- 0.25 CNY
- Payout ratio
- 17.6%
- Ex-dividend date
- May 21, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 79.3M | 0.21 | 17.6% |
| 2024 | CNY 72.7M | 0.19 | - |
| 2023 | CNY 66.5M | 0.17 | 19.0% |
| 2022 | CNY 30.3M | 0.08 | 10.9% |
| 2021 | CNY 30.3M | 0.08 | 12.3% |
| 2020 | CNY 18.9M | 0.05 | 9.6% |
| 2019 | CNY 12.5M | 0.05 | 16.1% |
| 2018 | CNY 56.8M | 0.23 | 84.0% |
| 2017 | CNY 18.1M | 0.08 | 30.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 30:10 on May 16, 2016.
Who owns Hangzhou Zhongtai Cryogenic Technology Corp
- Insiders 39.61%
- Institutions 2.42%
- Public & others 57.97%
- Shares outstanding 386M
- Free float 230M
Hangzhou Zhongtai Cryogenic Technology Corp company profile
- Company name
- Hangzhou Zhongtai Cryogenic Technology Corp
- Ticker
- 300435.SHE
- ISIN
- CNE100001YY3
- Exchange
- Shenzhen Stock Exchange
- Sector
- Industrials
- Industry
- Machinery
- Employees
- 1,277
- Fiscal year end
- December
- Address
- No. 228 Golf Road, Hangzhou, China, 311402
- Phone
- 86 57 16341 5978
- Website
- hz-ztpe.com/index.php
About Hangzhou Zhongtai Cryogenic Technology Corp
Hangzhou Zhongtai Cryogenic Technology Corporation engages in the research and development, manufacturing, and service of cryogenic key equipment and plant packages in China. The company offers engineering package services, such as natural gas engineering, air separation, Syngas cryogenic separation, olefins separation, specialty gas, and chemical gas purification; EPC services; nitrogen production services; and hydrogen energy solutions, including hydrogen production, hydrogen purification, and hydrogen liquefaction. It also manufactures plate-fin heat exchangers, spiral wound heat exchangers, cold boxes, distillation columns, cryogenic vessels, and skid integration products; and designs, manufactures, installs, conducts commissioning, and operates sets of air separation units. In addition, the company exports its products to the United States, the European Union, Africa, Central Asia, and Southeast Asia. Hangzhou Zhongtai Cryogenic Technology Corporation was founded in 2006 and is headquartered in Hangzhou, China.
Hangzhou Zhongtai Cryogenic Technology Corp management
3- Mr. Youhu ZhangVice Chairman & GM · born 1969
- Mr. Wei TangCFO, Deputy GM, Accounting Supervisor & Non-Independent Director · born 1982
- Ms. Juanping ZhouSecretary of the Board & Non-Independent Director · born 1979